Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Patten DK, Schultz BG, Berlau DJ
Understanding 5-amino-1mq is essential for researchers navigating this rapidly evolving field in 2026
Will keep ordering. Common Questions
Disclosure of interest: Elisabeth Hofstaetter: Medical Lead of Novartis Pharma GmbH, All other authors: nothing to disclose Poster Session I - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.02 - SECONDARY PREVENTION P389 - ESOC25-2231 ADDRESSING GENDER DISPARITIES IN CEREBROVASCULAR CLINICAL TRIALS: BARRIERS AND STRATEGIES FOR INCLUSION Virginia Cancelloni 1 , Victoria Rcker 2 , Kirsten Harvey 3 , Kirsten Haas 2 , Peter Heuschmann 2 , Bianca Koehler 1 , Mara Graziani 1 , Roland Veltkamp 3,4 , Valeria Caso 1 1 Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy, 2 Institute of Clinical Epidemiology and Biometry, University of Wrzburg, Wrzburg, Germany, 3 Department of Brain Sciences, Imperial College London, London, United Kingdom, 4 Department of Neurology, Alfried Krupp Krankenhaus Essen, Essen, Germany Background and Aims: The underrepresentation of women in cerebrovascular randomised control trials (RCTs) remains a pressing issue
Surg Endosc 2018;32:864-71
Are you healing faster
US$ 27.33
US$ 29.32
US$ 26.77
US$ 26.04
US$ 21.97
US$ 23.63
US$ 21.59